Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0355420020260030361
Journal of Korean Academy of Oral Health
2002 Volume.26 No. 3 p.361 ~ p.373
An analysis of oral health care supplies to leprous patients during 4 years



Abstract
Leprosy is chronic infectious disease caused by Mycobacterium leprosy which has 3 to 7 years latent period, invade primarily peripheral nerve and disseminate secondly skin and other tissues such as eye, mucous membrane in upper respiratory tract, muscle, bone and testis.
The purposes of this study were to analyze the frequencies and treatment times of oral health care supplies to leprotic patients and to obtain the baseline data for utilization of health¢¥ project and treatment of handicapped or disabled person.
The subjects were 7,491 in- and out-patients ( male : 4,511, female: 2,980) visited in the oral health care room in the Sorokdo General Hospital from 1995, May 1st to 1999, April 30th. We supplied them with oral health cares ranged from primary prevention to rehabilitation. For analysis, oral health supplies were divided into primary, second and tertiary preventive care according to preventive level for oral disease.
The results were as follows:
1. Among the patients received oral health care, 70-79 aged group was occupied 35.5% and followed 60-69 aged group(28.4%) and 50-59 aged group(15.0%).
2. Total frequency of treatment were 13,454. Among them, the primary preventive care was occupied 10.1%, the secondary preventive care was 29.3% and the tertiary preventive care was 60.6%, respectively.
3. Total treatment time for oral health care was about 1,623 hours. It was consumed 197 hours(12.1%) for the primary preventive care, 244 hours(15.0%) for the secondary preventive care. and 1,182 hours(72.8%) for the tertiary preventive care, respectively.
4. Among the tertiary preventive care, 60 patients were placed with Crown & Bridge and 290 patients were wared denture including partial and complete denture.
KEYWORD
FullTexts / Linksout information
 
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed